What Researchers Did
This review chapter explored the application of hyperbaric oxygen therapy (HBOT) for treating and preventing late radiation injuries, examining its safety for cancer patients and identifying potential areas for future research.
What They Found
Billing records from the United States indicate that delayed radiation injuries are the most frequent reason for hyperbaric treatments, making up approximately 40% of all billings. The review emphasizes that HBOT is beneficial as part of a multi-disciplinary approach, particularly when bone is involved and in conjunction with surgical interventions such as tissue flaps and skin grafts.
What This Means for Canadian Patients
For Canadian patients suffering from delayed radiation injuries, including those affecting soft tissue and bone, this review reinforces that HBOT can be a valuable part of a comprehensive treatment strategy. It suggests that combining HBOT with other therapies, such as surgery, may offer the best chance for successful recovery from these complex injuries.
Canadian Relevance
This study covers delayed radiation injury and osteoradionecrosis, which are Health Canada-recognized indications for hyperbaric oxygen therapy.
Study Limitations
As a review, this study synthesizes existing literature, meaning its conclusions are dependent on the quality and scope of the studies it analyzed rather than generating new clinical data.